Skip to main content
Clinical Trials/DRKS00025211
DRKS00025211
Recruiting
Not Applicable

Minimally invasive versus conventional surgical aortic valve replacement: retrospective multicentre-study

Robert-Bosch-Krankenhaus0 sites5,000 target enrollmentMay 20, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I35.0
Sponsor
Robert-Bosch-Krankenhaus
Enrollment
5000
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 20, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Robert-Bosch-Krankenhaus

Eligibility Criteria

Inclusion Criteria

  • Adult men and women (\>\= 18 years)
  • \-Indication for surgery: aortic valve vitium
  • \-Possibly additional procedures: supracommissural replacement of ascending aorta, atrial ablation, resection of left atrial appendage, subvalvular resection (Morrows operation).
  • \-Informed consent to study participation (given during follow up visitation)

Exclusion Criteria

  • \-Emergency operation
  • \-Re\-operation
  • \-Endocarditis
  • \-Combined surgery other than above\-mentioned
  • \-Denial or inability of consent to study participation

Outcomes

Primary Outcomes

Not specified

Similar Trials